SCHEMBL6821115

SCHEMBL6821115

CCNC(=O)Nc1cc(Br)ccc1Nc1ccc(C(=O)c2ccccc2C)c(F)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 10/20 0.63
MAPK12 P53778 10/20 0.63
MAPK11 Q15759 10/20 0.63
MAPK14 Q16539 10/20 0.63
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
GAA P10253 1/20 0.38
PTGFR P43088 1/20 0.38
MEN1 O00255 2/20 0.38
MAPT P10636 2/20 0.38
KMT2A Q03164 2/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
TP53 P04637 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
ABCG2 Q9UNQ0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6824376 0.89 MAPK14 (0.81) MAPK13MAPK12MAPK11MAPK14NPC1
SCHEMBL6907054 0.88 MAPK13 (0.57) MAPK13MAPK12MAPK11MAPK14NPC1
SCHEMBL6824663 0.87 MAPK13 (0.48) MAPK13MAPK12MAPK11MAPK14NPC1
SCHEMBL6821145 0.86 MAPK13 (0.60) MAPK13MAPK12MAPK11MAPK14NPC1
SCHEMBL6905834 0.84 MAPK13 (0.53) MAPK13MAPK12MAPK11MAPK14NPC1
SCHEMBL27513914 0.84 MAPK13 (0.48) MAPK13MAPK12MAPK11MAPK14NPC1
SCHEMBL6817035 0.84 MAPK1 (0.52) MAPK13MAPK12MAPK11MAPK14NPC1
SCHEMBL6817036 0.84 MAPK1 (0.52) MAPK13MAPK12MAPK11MAPK14NPC1
SCHEMBL5173305 0.83 MAPK13 (0.61) MAPK13MAPK12MAPK11MAPK14NPC1
SCHEMBL6824188 0.81 MAPK14 (0.69) MAPK13MAPK12MAPK11MAPK14LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1210325-B1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMA AS (DK) 2004-10-06 EP claimed
US-6750253-B1 INHIBITION OR DOWN REGULATION OF THE CYTOKINES IS POSSIBLY DUE TO AN INHIBITION OF MAP KINASES LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2004-06-15 US claimed
EP-1210325-A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 2002-06-05 EP claimed
WO-2001005751-A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) (DK) 2001-01-25 WO claimed
EP-1210325-B1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMA AS (DK) 2004-10-06 EP disclosed
US-6750253-B1 INHIBITION OR DOWN REGULATION OF THE CYTOKINES IS POSSIBLY DUE TO AN INHIBITION OF MAP KINASES LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2004-06-15 US disclosed
EP-1210325-A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA LEO PHARMACEUTICAL PRODUCTS LTD. A/S (LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB) (DK) 2002-06-05 EP disclosed
WO-2001005751-A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) Leo Pharmaceutical Products Ltd. A/S (Løvens Kemiske Fabrik Produktionsaktieselskab) (DK) 2001-01-25 WO disclosed